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ABSTRACT 
Objective: Hot Melt Extrusion (HME) is one of the techniques for preparing a solid dispersion hydrophilic excipient known as a no solvents practical 
method to increase the solubility of drugs. Apigenin (APG) has properties that thermal stable with melting point 345-350 °C but very low solubility 
in the water around 1,35 µg/ml. The polymer is stable in the HME method are Soluplus and Kollidon VA 64. The study aims to optimize the kind of 
polymer in HME formulae to improve the solubility and dissolution rate of apigenin by solid dispersion using hot-melt extrusion.  
Methods: Apigenin 10–50% w/w and Kollidon®VA 64 or Soluplus® and combination of Kollidon®VA 64 and Soluplus® were mixed, and the 
resulting blends extruded using a twin-screw extruder (Teach-Line ZK25T). Characterization of apigenin extrudates conducted using scanning 
electron microscopy, thermogravimetric analysis, differential scanning calorimetry, Fourier transform infrared spectroscopy, powder X-ray 
diffractometry, and dissolution. 
Results: Solubility studies presented enhancement in apigenin of 10%/Soluplus®90%; 10% w/w apigenin/Kollidon®VA 64 (90%); and 33,3% 
w/w apigenin/Kollidon®VA 64 33,3% mix Soluplus® 33,3% increased more than 18,25; 16,18-and 8,52-fold in water, respectively. Furthermore 
dissolution studies showed enhancement in apigenin percent release of 10%/Soluplus®90%; 10% w/w apigenin/Kollidon®VA 64 90%; and 33,3% 
w/w apigenin/Kollidon®VA 64 33,3% mix Soluplus® 33,3% tablet apigenin HME up to 34,29%; 69,75% and 30,69%, respectively. 
Conclusion: The formulation of 10% w/w Apigenin and 90% Soluplus® using hot-melt extrusion able to increase water solubility approximately 
18,25-fold than raw material apigenin. 
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INTRODUCTION 
Apigenin is a phytochemical compound that contained in some fruits, 
herbs, and vegetables. The main source of Apigenin is celery (Apium 
graveolens L), parsley, and chamomile [1]. Apigenin (5,7,4-trihydroxy 
flavone) corresponds to the subclass of flavones, and it is present in 
minimal amounts in food [2]. The previous research showed that APG 
with dose 4,8 mg/kg BW has potential as anticalculi [3]. Although APG 
has much practical use, it faces an obstacle in the formulation because 
of limited solubility, especially when it is used for oral administration. 
APG solubility in water is insoluble 0.00135 mg/ml [4]. APG 
categorized as BSC (Biopharmaceutical Classification system) class II, 
which has high permeability but low solubility and weak acid with the 
solubility of 1.43, 1.56, and 2.16 µg/ml in pH 1.0, 6.8, and 7.5, 
respectively [5]. Apigenin solubility is influenced by pH, particle size, 
selected solvent, and temperature; hence it needs to overcome 
different barriers for successful apigenin delivery [6]. Many techniques 
used for improving chemical and physical properties including particle 
size reduction, micronization, physical modifications, nanosuspension, 
modification of crystal habit such as, pseudo polymorphs, polymorphs, 
salt formation, complexation, solubilization, and use of cyclodextrins 
which can enhance the solubility and dissolution rate of insoluble drug 
and solid dispersion [7]. However, limited studies concerning the 
application of these techniques apigenin for examples apigenin 
nanocrystals using supercritical antisolvent process [8], inclusion 
complex of apigenin-hydroxypropyl-β-cyclodextrin by using 
supercritical antisolvent process [9], cocrystal of apigenin [10], 
apigenin in binary {Transcutol®  + water} mixtures [11], Formulation 
and characterization of an apigenin-phospholipid phytosomes (APLC) 
[12], design and evaluation of a self-micro emulsifying drug delivery 
system for apigenin [13], improved solubility and oral bioavailability 
of apigenin via soluplus/pluronic f127 binary mixed micelles system 
[14], preparation and in vitro evaluation of apigenin loaded lipid 
nanocapsules [15]. Lack of several methods than HME are difficult to 
scale up the process, and requires a lot of organic solvents [16]. 
The solid dispersion has become an established solubilization 
technology for poorly water-soluble drugs, and it is the most promising 
successful in enhancing solubility. Since a solid dispersion is a modifier, a 
drug-polymer two-component system, the drug-polymer interaction is 
the determining factor in its design and performance [17]. Some of the 
practical aspects to consider for the preparation of solid dispersions, 
such as methods of physicochemical characterization, selection of 
carrier, along with an insight into the molecular arrangement of drugs in 
solid dispersions [18]. Dispersion techniques in carriers can conduct by 
hot spin mixing, co-evaporation, co-precipitation, freeze-drying, spray 
drying, and hot-melt extrusion (HME) [19]. The technique still rare in 
Indonesia is HME. Recently, many pharmacies material had prepared 
their solid dispersion using HME. However, in that consideration, no 
HME technique applies an APG. HME is an efficient technology for 
producing solid molecular distributions with considerable advantages 
over solvent-based processes such as spray drying and co-precipitation 
[20]. Spray drying has a report to enhance the solubility and dissolution 
of Ibuprofen microparticle [21]. Advantage of HME is superior to other 
techniques because the process is easy, no solvent is required, enhance 
dissolution rate for solid dispersion, mask the taste, and controlling and 
modifying drug release [22]. APG suitable for HME method using high 
energy because it has a high melting point 345-350 °C [23]. 
This study aimed to improve the solubility and dissolution of 
Apigenin. Two polymeric carriers Soluplus®, polyvinylpyrrolidone-
co-vinyl acetate 64 (Kollidon® VA 64), were selected via the hot-
melt extrusion process to investigate the solubility and dissolution 
of apigenin. The matrix use soluplus® and Kollidon® VA 64 and is 
mixed due to show the best and most suitable polymer for HME and 
has thermoplastic behavior, proper transition glass (Tg), high 
degradation temperature, and low toxicity [24]. 
MATERIALS AND METHODS 
Materials 
Apigenin for the standard purchase from Sigma-Aldrich, apigenin 
row material (Hefei Dielegance Biotechnology Co., Ltd), Soluplus®, 
International Journal of Applied Pharmaceutics 
ISSN- 0975-7058                    Vol 13, Special Issue 3, 2021 
Stiani et al. 
Int J App Pharm, Vol 13, Special Issue 3, 2021, 47-52 
4th International Seminar on Pharmaceutical Science and Technology 2020              | 48 
and Kollidon® VA 64 (BASF-Megasetia), reagents used in this study 
was of analytical grade, twin-screw extruder (Teach-Line ZK25T) in 
Polytechnique STMI Jakarta. 
Methods 
HME preparation  
Hot Melt Extrusion Apigenin 10–50% w/w and Soluplus®, Kollidon® 
VA 64 (table 1) mix using a mixer (IKA EUROSTAR) for 10 min. The 
resulting concrete mixture blends extruded using a twin-screw 
extruder (Teach-Line ZK25T) at the screw speed of 100 rpm, at a 
temperature 140 °C and 180 °C. All extrudates were milled and 
sieved through an ASTM 35 mesh to obtain a uniform particle size 
[25].  
Thermogravimetric analysis 
Thermogravimetric analysis (TGA) perform for apigenin, Soluplus®, 
Kollidon® VA 64, and mixed to evaluate their stability at the 
extrusion temperatures. Approximately 10–15 mg of apigenin, 
polymers, as well as physical mixtures, was heated from 30 °C to 
300 °C at a heating rate of 20 °C/min (HITACHI, STA7300) [25]. 
 
Table 1: Apigenin composition for HME 
Formulation Apigenin (%) Soluplus® Kollidon® VA 64 
F1 10 90 - 
F2 20 80 - 
F3 40 60 - 
F4 10 - 90 
F5 20 - 80 
F6 40 - 60 
F7 50 25 25 
F8 33,3 33,3 33,3 
F9 20 40 40 
F10 14,2 42,9 42,9 
 
Differential scanning calorimetry 
Differential scanning calorimetry (DSC) studies obtained using 
Perkin Elmer Pyris 1 DSC equipped with Pyris manager software 
(PerkinElmer Life and Analytical Sciences). Approximately 2–4 mg of 
apigenin, extrudates were heated from 30 °C to 400 °C at a heating 
rate of 10 °C/min [4]. 
X-ray diffraction (XRD)  
The samples were analyzed by XRD pattern using an X-ray powder 
diffractometer with a rotating anode (Philips, PW 2213/30) and Cu 
Ka1 radiation generated at 30 mA and 50 kV. The scanning rate was 
5°/min from 5 to 60° [26].  
Scanning electron microscopy 
The morphology and physical state of the extrudates evaluated using 
Scanning electron microscopy (SEM) analysis. Samples were 
mounted on adhesive carbon pads placed on aluminum and were 
sputter-coated with gold using ion sputter (HITACHI MC1000) in a 
high vacuum evaporator. HITACHI SU3500 scanning electron 
microscope operating (SEM) at an accelerating voltage of 10 kV used 
for imaging [25]. 
Fourier transforms infrared spectroscopy 
Fourier transforms infrared spectroscopy (FTIR) spectra of 
apigenin, polymeric carriers, physical mixtures, as well as extrudates 
were performed using IR prestige-21 SHIMAZU FTIR. Apigenin 5 mg 
of each sample was mixed with 200 mg KBR and compressed into 
pellet and the scanning range was 400–4000 cm-1, and the resolution 
was 1 cm-1 [25]. 
Solubility test 
The solubility was determined at saturated water for formulations 
F1-F10 and optimum formula as well as pure apigenin. Samples 
equivalent to approximately 100 mg of apigenin each put into a flask 
containing 100 ml of aquadest shaken in 24 h. Then filtered and 
diluted using aquadest until 10 ppm by adding ethanol 96%. A 
sample volume of 1 ml collected and detected with 
spectrophotometer (SPECORD 200) wavelength for apigenin 
detection set at ⁁m ax 336 nm  [10, 25]. 
In vitro drug release 
A tablet with 8% primogel equivalent to 58,08 mg apigenin of each 
extrudate as well as pure apigenin and in vitro drug release profiles 
run using a USP type II dissolution apparatus. The used dissolution 
medium was 900 ml of 0.4% SDS maintained at 37 °C. A sample 
volume of 5 ml taken at 5, 10, 15, 30, 45, 60, 120 min, filtered, and 
analyzed using a spectrophotometer; then, 5 ml of fresh dissolution 
medium was added back to the dissolution vessel at each time point 
to maintain the volume [26]. 
RESULTS AND DISCUSSION 
All formulation conducted processing temperatures, TGA data showed 
no decrease in sample weight, decomposition held up 250 °C, which 
indicated that all formulations in the study were stable under all 
applied extrusion temperatures is 140 °C can be seen on fig. 1.  
 
 
Fig. 1: TGA all formulation 
 
XRD data showed pure apigenin, the physical mixture is crystalline, 
but with HME change crystallin form to amorf so that solubility can 
increase, all the extrudates showed in fig. 2.  
The solubility of apigenin enhance after prepared by HME, formula 
1, formula 4, and formula 8 is the highest solubility (table 2). In this 
research, we optimize temperature and screw with hot melt 
extrusion for three formulations are F1 apigenin 10% and Soluplus® 
90%; F2 apigenin 10% and Kollidon® VA 64 90%; and F3 apigenin 
33,3%, Soluplus® 33,3%, mixed Kollidon® VA 64 33,3%. 
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Fig. 2: PXRD (a) pure apigenin, (b) Soluplus® and Kollidon® 
VA64, (c) PM APG-solu, (d) PM APG-koli, (e) PM APG-solu–koli, 
(f)10% w/w APG/Soluplus® 90%, (g) 20% w/w 
APG/Soluplus® 80%, (h) 40% w/w APG/Soluplus® 60%, (i) 
10% w/w APG/Kollidon® VA64 (90%), (j) 20% w/w 
APG/Kollidon® VA64 (80%), (k) 40% w/w APG/Kollidon® 
VA64 (60%), (l) 50%w/w APG-solu 25%-koli 25%, (m) 
33,3%w/w APG-solu 33,3%-koli 33,3%, (n) 20%w/w APG-solu 
40%-koli 40%, (o) 14%w/w APG-solu 43%-koli 43% 
Table 2: Separated solubility apigenin in water* 
Sample Dissolve concentration±SD (mg/l) 
Apigenin 1,0109±0,0015 
Formula 1 17,716±0,0011 
Formula 2 4,7031±0,001 
Formula 3 2,4682±0,001 
Formula 4 16,084±0,0061 
Formula 5 7,7754±0,0015 
Formula 6 8,9772±0,003 
Formula 7 3,8494±0,0030 
Formula 8 9,4122±0,0058 
Formula 9 6,5846±0,0032 
Formula 10 8,5639±0,0055 
*Avg±% in mg/l deviation, n=3 
 
 
Fig. 3: Solubility of apigenin 
 
Table 3: Processing parameters for HME 
Formulation Temperature ( °C) Screw speed (rpm) Extrudate image 
Apigenin: Soluplus 10: 90 110 5-100  no extrudate 
 120 5-100  no extrudate 
 130 5-100  no extrudate 
 140 5-90  Little bit extrudate 
 
 140 100  
 
Apigenin: Kollidon VA 64 10: 90 110 5-100  no extrudate 
 120 5-100  no extrudate 
 130 5-100  no extrudate 
 140 5-90 
 
 140 100 
 
Apigenin: Soluplus: Kollidon VA 64 33,3%:33,3%: 33,3% 110 5-100  no extrudate 
 120-170 5-100  no extrudate 
 180 100 
 
 190 100 
 
 210 100 
 
 
The hot-melt extrusion process carried out using a twin-screw 
extruder (Teach-Line ZK25T) standard screw configuration used in 
this study, which consists of five conveying zones and two mixing 
zones (fig. 4). 
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Fig. 4: Twin screw extruder 
 
The HME processing conditions for screw speed and extrusion 
temperatures are stable results good extrudate was greenish-yellow, 
transparent, and brittle in 140 °C and 100 rpm for polymer 
Soluplus® and Kollidon® separately although mixed Soluplus® and 
Kollidon® give the resulting extrudate was brown, brittle, not 
transparent, opaque in 180 °C and 100 rpm. All extrudates were 
milled using a coffee grinder and sieved to obtain a uniform particle 
size (table 3). 
Formula 1 has solubility 18,455 µg/ml, apigenin 1,011 µg/ml. 
Formula 1 has a 18,25-fold solubility increase compare to apigenin 
without HME, and it can see in fig. 5. 
 
Table 4: Separated solubility apigenin in water for optimum 
formula 





PM F1 6,100±0,0524 
PM F2 0,212±0,0094 
PM F3 0,456±0,0188 
 *Avg±% in mg/l deviation, n=3 
 
 
Fig. 5:The solubility of apigenin in the optimum formula 
 
Fourier transforms infrared spectroscopy (FTIR) 
There is a shift in the spectrum but does not form new bonds, 
indicating there any chemical change in solid dispersion. The loss of 
some peak in apigenin-like polymers means that solid dispersion has 
formed (fig. 6). 
 
Fig. 6: (a) Fourier transforms infrared spectroscopy (FTIR) 
spectra of apigenin, (b) 10% w/w APG with Soluplus 90%, (c) 
10% w/w APG with kollidon 90%, (d) 33,3% w/w APG mixed 
soluplus 33,3% and kollidon 33,3% 
 
DSC result results show that Apigenin has an endothermic peak up 
347,76 °C means a crystalline structure. In contrast, others do not 
have sharp peaks that apigenin wit HME is molecularly dispersed 
into the pores of polymer and possibility amorphous state due to 
solubility increase. Alternatively, all the extrudates showed the 
absence of crystalline melting peaks in DSC data (fig. 7). 
 
 
Fig. 7: Differential scanning calorimetry of extrudates 
 
Scanning electron microscopy images showed the absence of crystals 
in 10% w/w apigenin/Soluplus and kollidon indicating that apigenin 
was dispersed in the Soluplus and in the kollidon polymer carrier as an 
amorphous, but when apigenin, soluplus mixed by kollidon with the 
same comparison still have image crystallin. However, crystals were 
evident in all other formulations with different ratios. Below are 
pictures of apigenin before and after HME (fig. 8). 
The formula I have particle size smallest than the others is 685,1 nm; 
the smaller particle size can increase the solubility of the drug. 
 
Table 5: Drug loading and particle size of apigenin 
Formula Drug loading (%) (Particle size) (nm) 
Apigenin - 1743.33±15.63 
F1 (Apigenin: Soluplus 10: 90) 90% 685.1±8.77 
 F2 (Apigenin: Kollidon VA 64 10: 90) 96% 700.33±13.09 
F3 (Apigenin: Soluplus: Kollidon VA 64: 33.3:33.3:33.3) 78.31% 6222.67±337.7 
DrugLoading %, particle size in nm; Avg±deviation, n=3 
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Fig. 8: SEM image (a) pure apigenin, (b) Physical mixture, (c) Soluplus®, (d) Kollidon® VA64, (e) 10% w/w apigenin/Soluplus® 90%, (f) 
10% w/w apigenin/Kollidon® VA64, (g) 33,3% w/w apigenin/Soluplus® 33,3% mixed by 33,3% Kollidon® VA64 
 
Dissolution studies demonstrated enhancement in apigenin 
percent release of 10%/Soluplus®90%; 10% w/w 
apigenin/Kollidon®VA 64 90%; and 33,3% w/w 
apigenin/Kollidon®VA 64 33,3% mix Soluplus® 33,3% tablet 




Fig. 9: In vitro drug release HME tablet of Apigenin, ♦ pure Apigenin; ■ Form ulae 1 ; ▲ Form ulae 2; ><Formulae 3 
 
CONCLUSION 
Solid dispersion technique by Hot Melt Extrusion (HME) can 
improve the solubility and dissolution of Apigenin. Formula 1 with 
10% w/w Apigenin/90% soluplus® is the best formula in this 
research can increase the 18, 25-fold solubility of Apigenin in water. 
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